Kezdeti tapasztalatok a Sorin Perceval S aorta biológiai billentyű beültetésével [Early experiences with the Sorin Perceval S arteficial biological valve]

OBJECTIVES: We examined the Sorin Perceval S artificial biological valve implantation techniques, and present the initial experiences in our unit. METHODS: In the last 1.5 years, 27 patients had been implanted with Sorin Perceval S biological arteficial valve due to aortic valve disease. The device...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Csepregi László
Bari Gábor
Bitay Miklós
Hegedűs Zoltán
Varga Sándor
Iglói Gábor
Szabó-Biczók Antal
Hartyánszky István
Bogáts Gábor
Dokumentumtípus: Cikk
Megjelent: Akadémiai Kiadó 2016
Sorozat:MAGYAR SEBÉSZET 69 No. 2
doi:10.1556/1046.69.2016.2.2

mtmt:3126383
Online Access:http://publicatio.bibl.u-szeged.hu/13088
Leíró adatok
Tartalmi kivonat:OBJECTIVES: We examined the Sorin Perceval S artificial biological valve implantation techniques, and present the initial experiences in our unit. METHODS: In the last 1.5 years, 27 patients had been implanted with Sorin Perceval S biological arteficial valve due to aortic valve disease. The device was mainly used in high-risk patients, in reoperative circumstances, in cases of calcified aortic root, and in elderly patients. RESULTS: The valve implantation time, aortic cross clamp time is shorter, but the risk of the operation cannot be eliminated entirely, because of the high risk patients' severe comorbidities. Furthermore, we performed echocardiography in the postoperative period, which demonstrated that the valve function is excellent, the valve fitted tightly in the anulus, and there was no paravalvular leakage. CONCLUSIONS: The Sorin Perceval S biological arteficial aortic valve is safe to use in high risk patients, and the surgical procedure is easier in case of partial sternotomy, too.
Terjedelem/Fizikai jellemzők:54-57
ISSN:0025-0295